Medicines as a service : a new commercial model for big pharma in the postblockbuster world / / Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu.
The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions. Such innovation beyond drug development is consistent with the...
Saved in:
Superior document: | RAND Health occasional paper |
---|---|
: | |
TeilnehmendeR: | |
Year of Publication: | 2012 |
Edition: | 1st ed. |
Language: | English |
Series: | Occasional paper (Rand Corporation)
|
Physical Description: | 1 online resource (12 p.) |
Notes: | Description based upon print version of record. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993628539204498 |
---|---|
ctrlnum |
(CKB)2670000000232840 (EBL)981579 (OCoLC)804665552 (SSID)ssj0000870484 (PQKBManifestationID)11463549 (PQKBTitleCode)TC0000870484 (PQKBWorkID)10818478 (PQKB)10643748 (MiAaPQ)EBC981579 (Au-PeEL)EBL981579 (CaPaEBR)ebr10583965 (OCoLC)893183697 (EXLCZ)992670000000232840 |
collection |
bib_alma |
record_format |
marc |
spelling |
Mattke, Soeren. Medicines as a service [electronic resource] : a new commercial model for big pharma in the postblockbuster world / Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu. 1st ed. Santa Monica, Calif. : RAND, c2012. 1 online resource (12 p.) text txt computer c online resource cr RAND Health occasional paper Description based upon print version of record. Medicines as a Service The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions. Such innovation beyond drug development is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models. English Includes bibliographical references. Pharmaceutical services. Pharmaceutical industry. Klautzer, Lisa. Mengistu, Tewodaj. RAND Health. Occasional paper (Rand Corporation) |
language |
English |
format |
Electronic eBook |
author |
Mattke, Soeren. |
spellingShingle |
Mattke, Soeren. Medicines as a service a new commercial model for big pharma in the postblockbuster world / RAND Health occasional paper Medicines as a Service |
author_facet |
Mattke, Soeren. Klautzer, Lisa. Mengistu, Tewodaj. RAND Health. RAND Health. |
author_variant |
s m sm |
author2 |
Klautzer, Lisa. Mengistu, Tewodaj. RAND Health. |
author2_variant |
l k lk t m tm |
author2_role |
TeilnehmendeR TeilnehmendeR TeilnehmendeR |
author_corporate |
RAND Health. |
author_sort |
Mattke, Soeren. |
title |
Medicines as a service a new commercial model for big pharma in the postblockbuster world / |
title_sub |
a new commercial model for big pharma in the postblockbuster world / |
title_full |
Medicines as a service [electronic resource] : a new commercial model for big pharma in the postblockbuster world / Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu. |
title_fullStr |
Medicines as a service [electronic resource] : a new commercial model for big pharma in the postblockbuster world / Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu. |
title_full_unstemmed |
Medicines as a service [electronic resource] : a new commercial model for big pharma in the postblockbuster world / Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu. |
title_auth |
Medicines as a service a new commercial model for big pharma in the postblockbuster world / |
title_new |
Medicines as a service |
title_sort |
medicines as a service a new commercial model for big pharma in the postblockbuster world / |
series |
RAND Health occasional paper |
series2 |
RAND Health occasional paper |
publisher |
RAND, |
publishDate |
2012 |
physical |
1 online resource (12 p.) |
edition |
1st ed. |
contents |
Medicines as a Service |
isbn |
0-8330-7646-9 |
callnumber-first |
H - Social Science |
callnumber-subject |
HD - Industries, Land Use, Labor |
callnumber-label |
HD9665 |
callnumber-sort |
HD 49665.5 M38 42012 |
illustrated |
Not Illustrated |
dewey-hundreds |
300 - Social sciences |
dewey-tens |
360 - Social problems & social services |
dewey-ones |
362 - Social welfare problems & services |
dewey-full |
362.29/90941 |
dewey-sort |
3362.29 590941 |
dewey-raw |
362.29/90941 |
dewey-search |
362.29/90941 |
oclc_num |
804665552 893183697 |
work_keys_str_mv |
AT mattkesoeren medicinesasaserviceanewcommercialmodelforbigpharmainthepostblockbusterworld AT klautzerlisa medicinesasaserviceanewcommercialmodelforbigpharmainthepostblockbusterworld AT mengistutewodaj medicinesasaserviceanewcommercialmodelforbigpharmainthepostblockbusterworld AT randhealth medicinesasaserviceanewcommercialmodelforbigpharmainthepostblockbusterworld |
status_str |
n |
ids_txt_mv |
(CKB)2670000000232840 (EBL)981579 (OCoLC)804665552 (SSID)ssj0000870484 (PQKBManifestationID)11463549 (PQKBTitleCode)TC0000870484 (PQKBWorkID)10818478 (PQKB)10643748 (MiAaPQ)EBC981579 (Au-PeEL)EBL981579 (CaPaEBR)ebr10583965 (OCoLC)893183697 (EXLCZ)992670000000232840 |
carrierType_str_mv |
cr |
hierarchy_parent_title |
RAND Health occasional paper |
is_hierarchy_title |
Medicines as a service a new commercial model for big pharma in the postblockbuster world / |
container_title |
RAND Health occasional paper |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField |
_version_ |
1799264568814338048 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02148nam a2200541 a 4500</leader><controlfield tag="001">993628539204498</controlfield><controlfield tag="005">20240516210422.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr -n---------</controlfield><controlfield tag="008">120810s2012 cau ob 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0-8330-7646-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)2670000000232840</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EBL)981579</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)804665552</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SSID)ssj0000870484</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PQKBManifestationID)11463549</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PQKBTitleCode)TC0000870484</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PQKBWorkID)10818478</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(PQKB)10643748</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)EBC981579</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL981579</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaPaEBR)ebr10583965</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)893183697</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)992670000000232840</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">HD9665.5</subfield><subfield code="b">.M38 2012</subfield></datafield><datafield tag="082" ind1="0" ind2="0"><subfield code="a">362.29/90941</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mattke, Soeren.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Medicines as a service</subfield><subfield code="h">[electronic resource] :</subfield><subfield code="b">a new commercial model for big pharma in the postblockbuster world /</subfield><subfield code="c">Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Santa Monica, Calif. :</subfield><subfield code="b">RAND,</subfield><subfield code="c">c2012.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (12 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">RAND Health occasional paper</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based upon print version of record.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Medicines as a Service</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions. Such innovation beyond drug development is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical services.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Klautzer, Lisa.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mengistu, Tewodaj.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">RAND Health.</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Occasional paper (Rand Corporation)</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-05-17 03:21:48 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2012-08-26 09:06:03 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5350500610004498&Force_direct=true</subfield><subfield code="Z">5350500610004498</subfield><subfield code="b">Available</subfield><subfield code="8">5350500610004498</subfield></datafield></record></collection> |